tiprankstipranks
Trending News
More News >
Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ:SNDX
US Market

Syndax Pharmaceuticals (SNDX) Income Statement

Compare
911 Followers

Syndax Pharmaceuticals Income Statement

Last quarter (Q4 2025), Syndax Pharmaceuticals's total revenue was $68.48M, an increase of 791.68% from the same quarter last year. In Q4, Syndax Pharmaceuticals's net income was $-68.01M. See Syndax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 172.35M$ 23.68M$ 0.00$ 0.00$ 139.71M
Gross Profit
$ 165.38M$ 22.85M$ 0.00$ 0.00$ 139.71M
Operating Expenses
$ 438.47M$ 362.53M$ 229.95M$ 151.76M$ 113.49M
Depreciation and Amortization
$ 6.00K$ 8.00K$ 12.00K$ 33.00K$ 43.00K
EBITDA
$ -251.64M$ -313.82M$ -209.14M$ -146.17M$ 26.87M
Operating Income
$ -273.08M$ -339.67M$ -229.95M$ -151.76M$ 26.22M
Other Income/Expenses
$ -12.34M$ 20.91M$ 20.59M$ 2.42M$ -1.29M
Pretax Income
$ -285.42M$ -318.76M$ -209.36M$ -149.34M$ 24.93M
Net Income
$ -285.42M$ -318.76M$ -209.36M$ -149.34M$ 24.93M
Per Share Metrics
Basic EPS
$ -3.30$ -3.73$ -2.98$ -2.46$ 0.48
Diluted EPS
$ -3.30$ -3.73$ -2.98$ -2.46$ 0.48
Weighted Average Shares Outstanding
86.62M 85.62M 70.37M 60.76M 52.06M
Weighted Average Shares Outstanding (Diluted)
86.62M 85.62M 70.37M 60.76M 52.06M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History